Olerup, Conexio Ink Deal for HLA Sequencing Products, Software

May 04, 2011

NEW YORK (GenomeWeb News) –Transplantation molecular diagnostics firm Olerup today announced a deal to market, sell, and distribute Conexio's HLA sequencing products and software.

The agreement covers Conexio's SBT Resolver products, which are locus-specific PCR-based HLA sequencing-based typing reagents. Included in the deal are SBT kits and a version of the Assign sequence analysis software. Olerup and its sub-distributors will sell Conexio's products.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Asked to Give DNA Back

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

CCR5 Gene Mortality Paper Retracted

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

Catch It Before Being Hospitalized

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

PNAS Studies Look at Lung Cancer Models, Height in Ancient Europeans, More

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.

Featured White Papers

BlueBee Data Security & Compliance

Type 1 Interferon Gene Expression Analysis: Precision Medicine in Lupus

Oct

21

Featured Webinar

Broad Genomic Testing for Oncology Clinical Trials and Clinical Practice

Genomics is a key element in the potential of precision medicine to transform oncology.

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Menu